HIGHLIGHTS
- who: Bryce Wallis and collaborators from the Department of Molecular Pharmaceutics, College of Pharmacy, University of Utah, Salt Lake City, UT, USA have published the paper: The Challenges and Prospects of p53-Based Therapies in Ovarian Cancer, in the Journal: Biomolecules 2023, 159 of /2023/
- what: While this study showed utility in xenograft mice, it is still early to predict if this drug delivery system will make it to clinical trials. This study has only been performed in_vitro and the results have yet to be confirmed in_vivo or in a clinical setting; the lack of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.